Effect of rituximab on human in vivo antibody immune responses

Podobne knjige/članki

• Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in Type 1 diabetes
  od: Herold, Kevan C., et al.
  Izdano: (2011)
• Rituximab Selectively Suppresses Specific Islet Antibodies
  od: Yu, Liping, et al.
  Izdano: (2011)
• Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data
  od: Greenbaum, Carla J., et al.
  Izdano: (2012)
• Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
  od: Pescovitz, Mark D., et al.
  Izdano: (2009)
• Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Type 1 Diabetes
  od: Lachin, John M., et al.
  Izdano: (2011)